Australia markets close in 52 minutes
  • ALL ORDS

    7,747.60
    -24.20 (-0.31%)
     
  • ASX 200

    7,539.30
    -18.80 (-0.25%)
     
  • AUD/USD

    0.6935
    +0.0010 (+0.15%)
     
  • OIL

    73.52
    +0.13 (+0.18%)
     
  • GOLD

    1,889.60
    +13.00 (+0.69%)
     
  • BTC-AUD

    33,087.47
    -814.20 (-2.40%)
     
  • CMC Crypto 200

    526.03
    -10.82 (-2.02%)
     
  • AUD/EUR

    0.6421
    +0.0010 (+0.15%)
     
  • AUD/NZD

    1.0958
    +0.0024 (+0.22%)
     
  • NZX 50

    12,197.15
    +44.95 (+0.37%)
     
  • NASDAQ

    12,573.36
    -229.74 (-1.79%)
     
  • FTSE

    7,901.80
    +81.64 (+1.04%)
     
  • Dow Jones

    33,926.01
    -127.89 (-0.38%)
     
  • DAX

    15,476.43
    -32.77 (-0.21%)
     
  • Hang Seng

    21,160.25
    -500.22 (-2.31%)
     
  • NIKKEI 225

    27,718.96
    +209.50 (+0.76%)
     

Phreesia Sets Release Date for Fiscal Third Quarter 2023 Results

RALEIGH, N.C., October 28, 2022--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) ("Phreesia") today announced that it will release its fiscal third quarter 2023 financial results after the close of market trading on Thursday, December 8, 2022. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal third quarter results starting at 5:00 PM Eastern Time on the same day.

To participate in the company's live conference call and webcast, please dial (888) 350-3437, or (646) 960-0153 for international participants, using conference code number 4000153, or visit the "Events & Presentations" section of ir.phreesia.com. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

ABOUT PHREESIA

Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients in their healthcare and provides a modern, convenient experience, while enabling our clients to enhance clinical care and drive efficiency.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221028005024/en/

Contacts

Investors:
Balaji Gandhi
Phreesia, Inc.
investors@phreesia.com
(929) 506-4950

Media:
Maureen McKinney
Phreesia, Inc.
mmckinney@phreesia.com
(773) 330-8908